Takeda (TAK) U.S. Business president awarded 50,156 RSUs in ADS grant

Rhea-AI Filing Summary

Pacheco Rhonda Janice reported acquisition or exercise transactions in this Form 4 filing.

Takeda Pharmaceutical President, U.S. Business Unit, Rhonda Janice Pacheco received an equity grant of 50,156 restricted stock units, each representing one American Depositary Share. The award was granted at no cash cost to her as compensation rather than an open-market purchase.

The RSUs vest in three equal annual installments beginning on July 1, 2027, meaning she earns the shares over time if service conditions are met. Following this grant, she directly holds 199,408 American Depositary Shares, aligning a larger portion of her compensation with Takeda’s long-term performance.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Pacheco Rhonda Janice

Role President, U.S. Business Unit

Type	Security	Shares	Price	Value
Grant/Award	American Depositary Shares	50,156	$0.00	--

Holdings After Transaction: American Depositary Shares — 199,408 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 50,156 shares Price per share: $0.00 per share Direct holdings after grant: 199,408 shares +2 more

5 metrics

RSUs granted 50,156 shares Restricted stock units representing Takeda American Depositary Shares

Price per share $0.00 per share Equity compensation grant with no cash paid by executive

Direct holdings after grant 199,408 shares American Depositary Shares held directly after the reported transaction

Vesting schedule 3 equal annual installments RSUs vest annually beginning July 1, 2027

First vesting date July 1, 2027 Initial installment date for RSU vesting

Key Terms

restricted stock units (RSUs), American Depositary Shares, vest in three equal annual installments, grant, award, or other acquisition

4 terms

restricted stock units (RSUs) financial

"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

American Depositary Shares financial

"Each RSU represents a contingent right to receive one American Depositary Share."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

vest in three equal annual installments financial

"The RSUs vest in three equal annual installments beginning on July 1, 2027."

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/06/2026 - 06:05 PM Accepted by SEC EDGAR 07/06/2026 - 06:05 PM Learn about SEC filing dates

FAQ

What did Takeda (TAK) executive Rhonda Janice Pacheco report on this Form 4?

Rhonda Janice Pacheco reported receiving a grant of 50,156 restricted stock units tied to Takeda American Depositary Shares. This is a stock-based compensation award, not an open-market share purchase or sale, and increases her equity stake in the company.

How many Takeda (TAK) shares did Rhonda Pacheco acquire in this transaction?

She acquired 50,156 restricted stock units, each representing one American Depositary Share of Takeda. The grant price is shown as zero because it is an equity award, so she did not pay cash for these shares at the time of the grant.

How many Takeda (TAK) shares does Rhonda Pacheco hold after the Form 4 transaction?

After the reported grant, Rhonda Pacheco directly holds 199,408 American Depositary Shares of Takeda. This figure includes the newly awarded restricted stock units and provides a snapshot of her direct ownership position following the compensation grant.

What is the vesting schedule for Rhonda Pacheco’s new Takeda (TAK) RSU award?

The restricted stock units vest in three equal annual installments beginning on July 1, 2027. This means one‑third of the award vests each year over three years, encouraging longer-term alignment with Takeda’s performance and continued service by the executive.

Is Rhonda Pacheco’s Takeda (TAK) Form 4 transaction a stock purchase or sale?

The transaction is not a market purchase or sale. It is classified as a grant or award acquisition, where Rhonda Pacheco received 50,156 restricted stock units as compensation, with no cash price per share listed in the filing’s transaction details.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pacheco Rhonda Janice

(Last) (First) (Middle)

500 KENDALL STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, U.S. Business Unit

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
American Depositary Shares	07/01/2026		A(1)		50,156	A	$0	199,408	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.

Remarks:

	/s/ Kate Huleatt, by power of attorney, for Rhonda J. Pacheco	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)